
NATCO Pharma shares sinks 28% in 2 days on Q3 earnings miss, brokerage downgrade
Shares of NATCO Pharma tumbled as much as 10% on Friday to Rs 876.15 on the BSE, extending a two-day slump to 28% after the company posted a sharp decline in third-quarter profit and brokerage Nuvama Institutional Equities slashed its target price citing weak business prospects. The stock plunged 20% on Thursday to Rs 975.05,…